May 26, 2022 article Open access A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia Nature Medicine DOI: 10.1038/s41591-022-01819-x Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 8 stored of 360 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia 2025 Leukemia article Immunology and Microbiology Immunotherapy and Immune Responses Open access 4 citations Resolving inter- and intra-patient heterogeneity in NPM1-mutated AML at single-cell resolution 2025 Leukemia article Medicine Acute Myeloid Leukemia Research Open access 7 citations Resolving inter- and intra-patient heterogeneity in NPM1- mutated AML at single-cell resolution 2024 medRxiv preprint Medicine Acute Myeloid Leukemia Research Open access 0 citations Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia 2024 Nature Communications article Medicine Acute Myeloid Leukemia Research Open access 34 citations A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML 2024 npj Precision Oncology article Medicine Acute Myeloid Leukemia Research Open access 14 citations Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses 2024 Leukemia article Medicine Acute Myeloid Leukemia Research Open access cited by 1 patent 35 citations Mapping AML heterogeneity – multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses 2023 medRxiv preprint Medicine Acute Myeloid Leukemia Research Open access 4 citations Single cell guided deconvolution of bulk transcriptomics recapitulates differentiation stages of acute myeloid leukemia and predicts drug response 2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Acute Myeloid Leukemia Research Open access 1 citations 8 results References 0